Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167)

Withdrawn

• Conditions: Arthritis, Rheumatoid

• Registration Number: NCT01313871
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

The study will assess the disease severity and treatment patterns of rheumatoid arthritis in Eastern European, Middle Eastern, and North African countries.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-03-10
• Study First Submitted QC: 2011-03-10
• Study First Posted: 2011-03-14
• Study Start: 2011-08
• Primary Completion: 2012-07
• Study Completion: 2012-11
• Status Verified: 2015-05
• Last Update Submitted: 2015-05-29
• Last Update Posted: 2015-06-01

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants with low, moderate, or high disease activity as assessed by the Disease Activity Score using 28 joint counts (DAS28)	Day of enrollment (Day 0)

Secondary Outcome Measures

Name	Time	Method
The number of participants with rheumatoid arthritis visiting participating sites in the course of one year	One year
Number of participants with different degrees of disability as assessed by the Health Assessment Questionnaire (HAQ).	Day of enrollment (Day 0)
Number of participants treated with non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDS), corticosteroids, and/or biologics	Day of enrollment (Day 0)